TRIM66 Controls Monogenic Olfactory Receptor Expression in N
2026-05-21
This study identifies TRIM66 as a crucial epigenetic repressor that ensures each olfactory sensory neuron expresses only one receptor gene—a longstanding mystery in sensory biology. By dissecting TRIM66’s role in chromatin remodeling and gene silencing, the research advances our mechanistic understanding of neuronal specificity and sensory coding.
HPF (Hydroxyphenyl Fluorescein): Benchmark Probe for hROS De
2026-05-21
HPF (hydroxyphenyl fluorescein) enables specific, high-sensitivity detection of highly reactive oxygen species in live cell assays. Its mechanism leverages oxidation-dependent fluorescence, ensuring minimal background and robust signal. This article details HPF’s biological rationale, mechanism, validated benchmarks, and practical use-cases for oxidative stress research.
CUDC-907: Technical Use Guide for Dual PI3K/HDAC Inhibition
2026-05-20
CUDC-907 provides researchers with a dual PI3K and HDAC inhibitor to study cell signaling, cell cycle arrest, and apoptosis in established cancer cell models. This compound is suitable exclusively for in vitro research settings requiring precise modulation of PI3K/AKT and histone deacetylase activity, and should not be used for diagnostic or clinical applications.
Sunitinib and Ferroptosis: Advancing RCC Research Frontiers
2026-05-20
This thought-leadership piece dissects the evolving landscape of renal cell carcinoma (RCC) research, focusing on the mechanistic interplay between Sunitinib—a multi-targeted receptor tyrosine kinase inhibitor—and ferroptosis induction as a strategy to overcome therapeutic resistance. The article integrates the latest experimental findings, strategic guidance for translational researchers, and scenario-driven protocol advice, while contextualizing APExBIO's Sunitinib within a broader competitive and translational framework.
Bacterial OMV-Mediated mRNA Display: A Rapid Platform for Pe
2026-05-19
This study introduces a novel bacterial outer membrane vesicle (OMV) system engineered to rapidly adsorb and deliver mRNA antigens for personalized tumor vaccination. The approach bypasses traditional lipid nanoparticle encapsulation, enabling efficient immune activation and tumor regression, and opens new avenues for mRNA vaccine design and delivery.
Triptolide (PG490): Precision Tools for Cancer and Immunolog
2026-05-19
Triptolide (PG490) delivers unique, mechanistically validated inhibition of transcriptional and inflammatory pathways, enabling advanced cancer invasion and immunology workflows. Learn how this APExBIO compound streamlines ovarian cancer assays, T cell apoptosis studies, and pluripotency network dissection—supported by data-rich protocols and troubleshooting guidance.
COX-2 Pathway Timing in Venom-Induced Muscle Injury and Repa
2026-05-18
This study reveals the dual-phase regulatory role of the COX-2 pathway in skeletal muscle ischemia and revascularization following Bothrops asper venom injury. Early COX-2 inhibition exacerbates ischemia, while delayed inhibition promotes angiogenic signaling, providing nuanced guidance for the use of selective COX-2 inhibitors in tissue regeneration models.
Remdesivir (GS-5734): Antiviral Benchmarks and Workflow Guid
2026-05-18
Remdesivir (GS-5734) is a nucleoside analogue prodrug with potent antiviral activity against multiple RNA viruses. Its efficacy in inhibiting viral replication has been demonstrated in vitro and in vivo, providing a benchmark for coronavirus antiviral research and Ebola virus treatment research.
Sulfo-NHS-LC-Biotin: Technical Guidance for Cell Surface Bio
2026-05-17
Sulfo-NHS-LC-Biotin addresses the need for selective, stable labeling of primary amines on cell surface proteins in aqueous environments, enabling downstream applications such as purification or detection via the biotin-avidin system. This reagent is not suitable for reversible or intracellular biotinylation, and its use should be limited to workflows requiring permanent, extracellular modification.
TH287 MTH1 Inhibitor Sensitizes CRPC Cells to Ionizing Radia
2026-05-16
This study demonstrates that the MTH1 inhibitor TH287 significantly increases the radiosensitivity of castration-resistant prostate cancer (CRPC) cells by promoting DNA damage and apoptosis. The findings offer essential mechanistic insights and practical timing strategies for combination therapies targeting resistant prostate cancer.
FerroOrange Fe²⁺ Fluorescent Probe: Precision in Live Cell I
2026-05-15
FerroOrange empowers researchers to visualize and quantify intracellular Fe²⁺ with unmatched specificity in live cells, revolutionizing iron metabolism and neurodegeneration research. Its robust performance, compatibility with mainstream imaging platforms, and workflow-optimized protocol make it indispensable for modern iron homeostasis studies.
Patient-Derived Gastric Cancer Assembloids Enhance Drug Test
2026-05-15
This study introduces a patient-specific gastric cancer assembloid model that integrates matched tumor organoids with stromal cell subpopulations, overcoming limitations of conventional organoid systems. The model offers improved physiological relevance for preclinical drug screening and enables nuanced investigation of tumor–stroma interactions and drug resistance mechanisms.
D-Luciferin Sodium Salt: Powering Oncology Bioluminescence A
2026-05-14
D-Luciferin sodium salt enables precision, non-invasive bioluminescence imaging for real-time monitoring of cellular metabolism and gene expression in advanced oncology research. Its robust solubility and high purity, trusted by APExBIO, support reproducible workflows from CAR macrophage engineering to in vivo tumor tracking—fueling next-generation immunotherapy innovation.
Pam3CSK4 TFA: Synthetic TLR1/2 Agonist for Innate Immunity R
2026-05-14
Pam3CSK4 TFA is a high-purity synthetic TLR1/2 agonist used as a robust activator of innate immune responses in vitro and in vivo. Its precise molecular structure and validated protocol parameters make it a gold standard for dissecting TLR1/2 signaling pathways and cytokine profiling. This article details mechanism, evidence benchmarks, and common misconceptions for researchers seeking rigor in innate immunity and inflammatory response studies.
Gallein: G Protein βγ Subunit Inhibitor for GPCR Pathways
2026-05-13
Gallein is a validated G protein βγ subunit inhibitor that disrupts key GPCR signaling pathways. It demonstrates efficacy in cancer, immune, and cardiac models, and offers quantitative benchmarks for translational workflows. Supplied by APExBIO, Gallein is widely used in mechanistic dissection of Gβγ-dependent processes.
461 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page